Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche Pharma sets up data analytics center in Hyderabad

Ruchika Sharma18 Oct 2022 12:15 PM IST

Hyderabad: With an aim to provide innovative data-driven solutions, Roche Pharma has set up a state-of-the-art Global Analytics and Technology...

Bhushan Akshikar appointed as GSK Pharma MD

Ruchika Sharma18 Oct 2022 11:20 AM IST

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced that the company has appointed Bhushan Akshikar as a Managing Director of the Company...

GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP

USFDA nod to GSK Menveo in new single-vial presentation to prevent invasive meningococcal disease

Ruchika Sharma18 Oct 2022 10:00 AM IST

"The Menveo one-vial presentation now comes in a ready to use single vial giving healthcare providers a more convenient option," GSK stated.

Zydus Pharma Roflumilast Tablets bags USFDA okay to treat COPD exacerbations

Ruchika Sharma17 Oct 2022 3:30 PM IST

Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable chronic lung disease which affects men and women worldwide.

Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan

Ruchika Sharma17 Oct 2022 2:30 PM IST

Denosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.

Indonesia bans cough syrup material linked to 70 children deaths in Gambia

Ruchika Sharma17 Oct 2022 1:30 PM IST

The BPOM reiterated that the four products linked to the deaths in Gambia are not registered in Indonesia, nor any other Maiden products.

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Zydus Lifesciences arm secures USFDA nod for tardive dyskinesia drug Valbenazine

Ruchika Sharma17 Oct 2022 12:30 PM IST

Ahmedabad: Zydus Lifesciences Limited's (formerly known as Cadila Healthcare Limited) subsidiary Zydus Worldwide DMCC has received tentative approval...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis gets positive EMA panel opinion for prostate cancer drug Pluvicto

Ruchika Sharma17 Oct 2022 11:32 AM IST

Pluvicto is a radioligand therapy combining a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope

Pfizer, BioNTech report positive early data from clinical trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in 18 years and older

Ruchika Sharma16 Oct 2022 4:00 PM IST

New York: Pfizer Inc. and BioNTech SE have announced early data from a Phase 2/3 clinical trial evaluating the safety, tolerability, and...

GSK to close commercial operations in Kenya next year

Ruchika Sharma16 Oct 2022 2:00 PM IST

The manufacturing facility in Kenya is operated by Haleon and GSK was importing medicines and vaccines, whose sales were being handled by its...

Takeda gets positive CHMP opinion recommending nod of Dengue Vaccine in EU, Dengue-endemic countries

Ruchika Sharma16 Oct 2022 12:00 PM IST

Japan: Takeda has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

Bayer Mirena approved in Europe for extended duration of use in contraception

Ruchika Sharma16 Oct 2022 10:00 AM IST

Berlin: Bayer has announced that it has positively concluded the European Workshare Procedure extending the duration of use for up to eight years...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok